Logo

American Heart Association

  2
  0


Final ID:

State of the Art Approaches in Circumventing Hypertrophic Cardiomyopathy in Danon Disease

  • Adler, Eric  ( UCSD , San Diego , California , United States )
  • Author Disclosures:
    Eric Adler: DO have relevant financial relationships ; Employee:Lexeo Therapeutics:Active (exists now) ; Consultant:Kiniska Pharmaceuticals:Past (completed) ; Consultant:Abbott:Past (completed) ; Consultant:Abiomed:Past (completed) ; Ownership Interest:Papillion Therapeutics:Active (exists now) ; Other (please indicate in the box next to the company name):Solid Biosciences:Past (completed) ; Research Funding (PI or named investigator):Rocket Pharmaceuticals:Past (completed) ; Royalties/Patent Beneficiary:Rocket Pharmaceuticals:Active (exists now) ; Individual Stocks/Stock Options:Lexeo Therapeutics:Active (exists now) ; Royalties/Patent Beneficiary:Lexeo Therapeutics:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available